Evelyne Daoust

Evelyne Daoust is an experienced professional in the pharmaceutical industry, currently serving as Head of Sales and Marketing for Neurology at Lundbeck since November 2012. In this role, Evelyne is responsible for the commercialization of an antipsychotic medication in collaboration with Otsuka. Previously, Evelyne held various leadership positions at Lundbeck, including regional business manager, where successful team development and national reimbursement recommendations were achieved. Prior experience at GSK spans over a decade, focused on blended learning strategies, product launches, and training for oncology specialty care. Evelyne holds a Bachelor of Science in Biomedical Science from Université du Québec à Trois-Rivières and an MBA from Université de Sherbrooke.